Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional CapacityMona Alotaibi, Mohit Jain, Anna R. Hemnes et al.|CHEST Journal|2022Cited by 27
Metabolomic Profiles of Scleroderma-PAH are different than idiopathic PAH and associated with worse clinical outcomesMona Alotaibi, Mohit Jain, Junzhe Shao et al.|medRxiv|2021Cited by 0